A Top 3 Revenue Producing, Publicly Traded Cannabis Stock

Trulieve Cannabis has 27 locations in Florida and is in the top 3 revenue producing, publicly traded cannabis stocks.

Trulieve is the first and leading medical cannabis company in the state of Florida, the third most populous state in the United States. Its vertically-integrated “seed-to-sale” operation has approximately 65% of the Florida market. With a patient base that grows approximately 10% month-to-month, it is poised for growth in this attractive market. Trulieve boasts over 150 SKUs and is constantly adding new, fresh, and exciting items to its product line. Its widespread dispensary network and large delivery fleet provides important, much-needed access to thousands of patients every day throughout the state. Trulieve is committed to growing its dispensary footprint in the state, constantly identifying new locations that will bring Trulieve closer to patients throughout the state, allowing many more people to have easier access to the medicine they need. Its first mover advantage in the state provides numerous benefits, including brand recognition and media attention. Strong financial performance, driven by sales to a loyal and dedicated group of patients affectionately called Trulievers, positions the company’s commitment to continue its pattern of growth.

Increasing growth is a primary focus to all of us at Trulieve. Growth benefits our investors and, most importantly, the patients who look to the company to continue to make the medicine available to them. We are increasing the number of dispensaries and constantly looking for new markets to serve. We are expanding our grow capabilities to allow us to have the inventory to satisfy the needs of our patients. Our R&D team continually monitors for new initiatives in the industry that they can develop to expand Trulieve’s product line. We continue to explore new extraction technologies. Trulieve sponsors various events throughout the state to introduce potential patients to the benefits of our products. We have educated an extensive doctor network who believe in and tout the benefits of Trulieve’s products to their patients. Finally, Trulieve is actively reviewing opportunities outside the state of Florida for possible partnership or acquisition. The company has already announced purchases of licenses in California and Massachusetts.

For more information on Trulieve Cannabis Corp. (TRUL:CSE) please fill out the form below.

Request Investor Kit